Development of novel bioadhesive granisetron hydrochloride spanlastic gel and insert for brain targeting and study their effects on rats

References

• Ahmed S, El-Setouhy DA, El-LatifBadawi AA, El-Nabarawi MA. (2014). Provesiculargranisetron hydrochloride buccal formulations: in vitro evaluation and preliminary investigation of in vivo performance. Eur J Pharm Sci 60:10–23.
   PubMed Web of Science ®Google Scholar
• Alam MI, Beg S, Samad A, et al. (2010). Strategy for effective brain drug delivery. Eur J Pharm Sci 40:385–403.
   PubMed Web of Science ®Google Scholar
• Alexis F, Pridgen E, Molnar LK, Farokhzad OC. (2008). Factors affecting the clearance and biodistribution of polymeric nanoparticles. Mol Pharm 5:505–15.
   PubMed Web of Science ®Google Scholar
• Bisht R. (2011). Brain drug delivery system: a comprehensive review on recent experimental and clinical findings. Int J Pharm Sci Res 2:792–806.
   Google Scholar
• Chaturvedi M, Kumar M, Pathak K. (2011). A review on mucoadhesive polymer used in nasal drug delivery system. J Adv Pharm Technol Res 2:215–22.
   PubMedGoogle Scholar
• Costantino HR, Illum L, Brandt G, et al. (2007). Intranasal delivery: physicochemical and therapeutic aspects. Int J Pharm 337:1–24.
   PubMed Web of Science ®Google Scholar
• Dae-Duk K. Drug absorbtionstudies: in situ, in vitro and insilicomodels. USA: Springer; 2007.
   Google Scholar
• El Nabarawi M, Abdelmonem R, Attia AM. (2016). Formulation and evaluation of intranasal granisetron hydrochloride spanlastic dispersions for postoperative and cancer associated therapies. Inventi Impact: Pharm Tech 2016:126–31.
   Google Scholar
• El-Hadidy GN. A pharmaceutical study on topical antifungal drug [M.Sc. Thesis]. Fac. Pharm., Cairo Univ. 2010.
   Google Scholar
• El-Nabarawi MA, Makky AM, El-Setouhy DA, et al. (2012). Development and characterization of ketorolac tromethamine (KT) orobuccAal FILMS. Int J Pharm Pharm Sci 4:186–93. [https://doi.org/WorldCat]
   Google Scholar
• Fang JY, Hwang TL, Leu YL. (2003). Effect of enhancers and retarders on percutaneous absorption of flurbiprofen from hydrogels. Int J Pharm 250:313–25.
   PubMed Web of Science ®Google Scholar
• Farid RM, Etman MA, Nada AH, Ebian AE. (2013). Formulation and in vitro evaluation of salbutamol sulphate in situ gelling nasal inserts. AAPS PharmSciTech 14:712–8.
   PubMed Web of Science ®Google Scholar
• Fukami J, Ozawa A, Yoshihashi Y, et al. (2005). Development of fast disintegrating compressed tablets using amino acid as disintegration accelerator: evaluation of wetting and disintegration of tablet on the basis of surface free energy. Chem Pharm Bull 53:1536–9.
   PubMed Web of Science ®Google Scholar
• Gabal YM, Kamal AO, Sammour OA, Elshafeey AH. (2014). Effect of surface charge on the brain delivery of nanostructured lipid carriers in situ gels via the nasal route. Int J Pharm 473:442–57.
   PubMed Web of Science ®Google Scholar
• Hawkins BT, Davis TP. (2005). The blood-brain-barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–85.
   PubMed Web of Science ®Google Scholar
• Hwang SH, Maitani Y, Qi XR, et al. (1999). Remote loading of diclofenac, insulin and fluorescein isothiocyanate labeled insulin into liposomes by pH and acetate gradient methods. Int J Pharm 179:85–95.
   PubMed Web of Science ®Google Scholar
• Kakkar S, Pal Kaur I. (2013). A novel nanovesicular carrier system to deliver drug topically. Pharm Dev Technol 18:673–85.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Bhandarij R, Bhandari S, Kakkar V. (2008). Potential of solid lipid nanoparticles in brain targeting. J Control Release 127:97–109.
   PubMed Web of Science ®Google Scholar
• Koleng J, Meginity J, Carbomer. (2006). In: Rowe RC, Heskey PJ, Owen SC, eds. The handbook of pharmaceutical excipients, 5th ed.. Washington DC: Pharmaceutical Press, London and American Pharmacists Association .
   Google Scholar
• Kozlovskaya L, Abou-Kaoud M, Stepensky D. (2014). Quantitative analysis of drug delivery to the brain via nasal route. J Control Release 189:133?40.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2004). Influence of the surface properties bit nanoparticle-mediated transport of drugs to the brain. J Nanosci Nanotechnol 4:484–8.
   PubMed Web of Science ®Google Scholar
• Kreuter J. (2001). Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47:65–81.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Ramge P, Petrov V, et al. (2003). Direct evidence that polysorbate-80-coated poly (butylcyanoacrylate) nanoparticles deliver drugs to the CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409–16.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Shamenkov D, Petrov V, et al. (2002). Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood–brain barrier. J Drug Target 10:317–25.
   PubMed Web of Science ®Google Scholar
• Kumar M, Misra A, Babbar AK, et al. (2008). Intranasal nanoemulsion based brain targeting drug delivery system of risperidone. Int J Pharm 358:285–91.
   PubMed Web of Science ®Google Scholar
• Osborne DV, Amann AH. (1990). Topical drug delivery formulations. New York (NY): Marcel Dekker, 381–8.
   Google Scholar
• Pardridge WM. (1998). CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70:1781–92.
   PubMed Web of Science ®Google Scholar
• Seager H. (1998). Drug-delivery products and the Zydis fast-dissolving dosage form. J Pharm Pharmacol 50:375–82.
   PubMed Web of Science ®Google Scholar
• Sherimeier S, Schmidt PC. (2002). Fast dispersible ibuprofen tablets. Eur J Pharm Sci 15:295–305.
   PubMed Web of Science ®Google Scholar
• Shivhare UD, Jain KB, Mathur VB, et al. (2009). Formulation development and evaluation of diclophinac sodium gel using water soluble polyacrylamide polymer. Digest J Nanomater Biostruct 4:285–90.
   Web of Science ®Google Scholar
• Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH. (2015). Duodenum-triggered delivery of pravastatin sodium via enteric surface-coated nanovesicularspanlastic dispersions: development, characterization and pharmacokinetic assessments. Int J Pharm 483:77–88.
   PubMed Web of Science ®Google Scholar
• Thorne RG, Pronk GJ, Padmanabhan V, Frey WH. (2004). Delivery of insulin-like growth factor-1 to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration. Neuroscience 127:481–96.
   PubMed Web of Science ®Google Scholar
• Van Dongen PAM. (1998). Brain-size in vertebrates. The central nervous system of vertebrates. Berlin (Germany): Springer, 2099–130.
   Google Scholar
• Vyas TK, Shahiwala A, Marathe S, Misra A. (2005). Intranasal drug delivery for brain targeting. Curr Drug Deliv 2:165–75.
   PubMedGoogle Scholar
• Wang YY, Hong CT, Chiu WT, Fang JY. (2001). In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int J Pharm 224:89–104.
   PubMed Web of Science ®Google Scholar
• Yong CS, Jung JH, Rhee JD, et al. (2001). Physicochemical characterization and evaluation of buccal adhesive tablets containing omeprazole. Drug Dev Ind Pharm 27:447–55.
   PubMed Web of Science ®Google Scholar
• Yu C, Meng J, Chen J, Tang X. (2009). Preparation of ergoloidmesylate submicron emulsions for enhancing nasal absorption and reducing nasal ciliotoxicity. Int J Pharm 375:16–21.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Jiang X, Jiang W, et al. (2004). Preparation of nimodipine-loaded microemulsion for intranasal delivery and evaluation on the targeting efficiency to the brain. Int J Pharm 275:85–96.
   PubMed Web of Science ®Google Scholar